SciSparc Signs Agreement for the Supply of CBD-rich Cannabis Oil for its Clinical Trial on Children with Autism Spectrum Disorder

MMP News AuthorFebruary 27, 2023
The cannabis oil will be used as a part of the Company‘s proprietary SCI-210 treatment combination of CBD and CannAmide™  TEL AVIV, Israel, Feb. 27, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of  ... Read More

CBD Gummies Market Size is Positioned to be worth US$ 7.27 Bn at a robust CAGR of 29% During the Forecast Period of 2022-32 | Latest Report by Future …

MMP News AuthorNovember 7, 2022
In North America geographical region, US is the largest shareholder with the total contribution of around 42%. The formulation of regulations pertaining to the legal or medical use of cannabinoid, particularly in California State, is responsible for such a higher sales of CBD gummies there /EIN News/ — DUBAI, United ... Read More